Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Raw Materials: 2012-2025

Historic Raw Materials for Innoviva (INVA) over the last 5 years, with Sep 2025 value amounting to $14.4 million.

  • Innoviva's Raw Materials rose 50.90% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year increase of 50.90%. This contributed to the annual value of $11.1 million for FY2024, which is 1.28% down from last year.
  • According to the latest figures from Q3 2025, Innoviva's Raw Materials is $14.4 million, which was up 36.28% from $10.5 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Raw Materials peaked at $14.4 million during Q3 2025, and registered a low of $5.8 million during Q3 2022.
  • Its 3-year average for Raw Materials is $10.0 million, with a median of $9.5 million in 2024.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 95.54% in 2023, then decreased by 1.28% in 2024.
  • Innoviva's Raw Materials (Quarterly) stood at $5.8 million in 2022, then surged by 95.54% to $11.3 million in 2023, then declined by 1.28% to $11.1 million in 2024, then surged by 50.90% to $14.4 million in 2025.
  • Its Raw Materials stands at $14.4 million for Q3 2025, versus $10.5 million for Q2 2025 and $10.6 million for Q1 2025.